GLIS2 and cancer: In the present study, we characterized EVs isolated from expanded and activated NKL using two-dimensional electrophoresis (2-DE)-based proteome analysis and evaluated their therapeutic potential against cancer both in vitro and in vivo to identify potent anticancer effectors of NKL-derived EVs that may help to develop an anticancer cocktail to treat cancer even without using the original EVs.